Download Docs
Export
Print

CONTRA-MAB

88081271 | Trademark

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed Aug. 16, 2018
Serial No. 88081271
Registered April 7, 2020
Registration No. 6,029,997
Class Genetically engineered proteins for diagnostic purposes; gene therapy and proteins, namely, antibodies and fusion proteins for the treatment of cancer; pharmaceutical substances and preparations namely, genetically engineered proteins for medical diagnostic use; pharmaceutical and biochemical preparations for the treatment of cancer; Biochemicals, namely, engineered proteins for the regulation of human, animal, plant, viral and microbial genes for clinical and medical laboratory use in human and animal therapeutics for the treatment of cancer, DNA diagnostics and bioinformatics for medical diagnostic purposes; 006; 018; 044; 046; 051; 052
CONTRA-MAB
Case Type Trademark
Status Registered. The registration date is used to determine when post-registration maintenance documents are due.
Last Updated: 4 days, 19 hours ago
Filing Date # Docket Text